Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached press release issued by the Company titled: Completion of the EU-GMP inspection at the Cuddalore facility of the Company. Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclose the transcript of the earnings conference call for the quarter ended December 31, 2022, conducted after the meeting of Board of Directors held on January 25, 2023, for your information and records. Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached press release issued by the Company titled: 'USFDA concludes inspection at Solara's Visakhapatnam (Vizag) facility with zero 483 inspectional observations.' Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about newspaper advertisement titled 'Notice of Postal Ballot' appeared in Business Standard and Pratahkal. Solara Active Pharma Sciences Ltd - 541540 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the notice of the Postal Ballot. Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of newspaper advertisement published on January 26, 2023, in the 'Business Standard' and 'Pratahkal' providing extract of the Unaudited Financial Results of the Company for the quarter ended December 31, 2022 Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached press release issued by the Company titled: Completion of the WHO PQ inspection at the Cuddalore facility of the Company
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q3 of FY23 Earnings Call held on January 25, 2023, on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update. Solara Active Pharma Sciences Ltd - 541540 - Appointment Of CEO
Pursuant to Regulation 30 read with Part A, Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR Regulations"), we wish to inform you that the Board of Directors of the Company has appointed Mr. Poorvank Purohit as Chief Executive Officer and as Key Managerial Personnel (KMP) with effect from February 3, 2023.